Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Trends in the Management of Small Renal Masses: A Survey of Members of the Endourological Society.

Mohapatra A, Potretzke AM, Weaver J, Anderson BG, Vetter J, Figenshau RS.

J Kidney Cancer VHL. 2017 Jul 20;4(3):10-19. doi: 10.15586/jkcvhl.2017.82. eCollection 2017.

2.

Trends of partial and radical nephrectomy in managing small renal masses.

Al Saidi IK, Alqasem KS, Gharaibeh ST, Qamhia NZ, Abukhiran I, Al-Daghmin AA.

Turk J Urol. 2017 Mar;43(1):42-47. doi: 10.5152/tud.2016.33667. Epub 2017 Jan 6.

3.

Intraoperative ultrasound control of surgical margins during partial nephrectomy.

Alharbi FM, Chahwan CK, Le Gal SG, Guleryuz KM, Tillou XP, Doerfler AP.

Urol Ann. 2016 Oct-Dec;8(4):430-433. doi: 10.4103/0974-7796.192107.

4.

Survival after partial and radical nephrectomy for high-risk disease: A propensity-matched comparison.

Maurice MJ, Zhu H, Kim S, Abouassaly R.

Can Urol Assoc J. 2016 Sep-Oct;10(9-10):E282-E289. Epub 2016 Sep 13.

5.

Repeat Robotic Partial Nephrectomy: Characteristics, Complications, and Renal Functional Outcomes.

Watson MJ, Sidana A, Diaz AW, Siddiqui MM, Hankins RA, Bratslavsky G, Linehan WM, Metwalli AR.

J Endourol. 2016 Nov;30(11):1219-1226. Epub 2016 Oct 20.

PMID:
27650937
6.

Nephrectomy Type Was Not Associated with a Subsequent Risk of Coronary Heart Disease: A Population-Based Study.

Chung SD, Huang CY, Wu ST, Lin HC, Huang CC, Kao LT.

PLoS One. 2016 Sep 16;11(9):e0163253. doi: 10.1371/journal.pone.0163253. eCollection 2016.

7.

Adherence to guideline recommendations for management of clinical T1 renal cancers in the Netherlands: a population-based study.

Aben KK, Osanto S, Hulsbergen-van de Kaa CA, Soetekouw PM, Stemkens D, Bex A.

World J Urol. 2016 Aug;34(8):1053-60. doi: 10.1007/s00345-016-1841-3. Epub 2016 May 13.

8.

Renal ablation using magnetic resonance-guided high intensity focused ultrasound: Magnetic resonance imaging and histopathology assessment.

Saeed M, Krug R, Do L, Hetts SW, Wilson MW.

World J Radiol. 2016 Mar 28;8(3):298-307. doi: 10.4329/wjr.v8.i3.298.

9.

Nephron-sparing surgery for Wilms tumor: A systematic review.

Vanden Berg RN, Bierman EN, Noord MV, Rice HE, Routh JC.

Urol Oncol. 2016 Jan;34(1):24-32. doi: 10.1016/j.urolonc.2015.07.003. Epub 2015 Aug 5. Review.

10.

Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study.

Lin WY, Liang FW, Lu TH.

PLoS One. 2015 May 20;10(5):e0126965. doi: 10.1371/journal.pone.0126965. eCollection 2015. Erratum in: PLoS One. 2015;10(6):e0130647.

11.

Natural history of small renal masses.

Zhang L, Li XS, Zhou LQ.

Chin Med J (Engl). 2015 May 5;128(9):1232-7. doi: 10.4103/0366-6999.156139. Review.

12.

Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.

Tan HJ, Meyer AM, Kuo TM, Smith AB, Wheeler SB, Carpenter WR, Nielsen ME.

Cancer. 2015 Mar 15;121(6):836-43. doi: 10.1002/cncr.29144. Epub 2014 Nov 19.

13.

Risk of chronic kidney disease after nephrectomy for renal cell carcinoma.

Choi SK, Song C.

Korean J Urol. 2014 Oct;55(10):636-42. doi: 10.4111/kju.2014.55.10.636. Epub 2014 Oct 10. Review.

14.

Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma.

Roos FC, Steffens S, Junker K, Janssen M, Becker F, Wegener G, Brenner W, Steinestel J, Schnoeller TJ, Schrader M, Hofmann R, Thüroff JW, Kuczyk MA, Wunderlich H, Siemer S, Hartmann A, Stöckle M, Schrader AJ; German Renal Cell Cancer Network.

BMC Cancer. 2014 May 26;14:372. doi: 10.1186/1471-2407-14-372.

15.

Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis.

Wang HH, Abern MR, Cost NG, Chu DI, Ross SS, Wiener JS, Routh JC.

J Urol. 2014 Oct;192(4):1196-202. doi: 10.1016/j.juro.2014.04.003. Epub 2014 Apr 13.

16.

Percutaneous ablation of the small renal mass-techniques and outcomes.

Gunn AJ, Gervais DA.

Semin Intervent Radiol. 2014 Mar;31(1):33-41. doi: 10.1055/s-0033-1363841. Review.

17.

Balancing cardiovascular (CV) and cancer death among patients with small renal masses: modification by CV risk.

Patel HD, Kates M, Pierorazio PM, Allaf ME.

BJU Int. 2015 Jan;115(1):58-64. doi: 10.1111/bju.12719. Epub 2014 Jul 27.

18.

Small renal masses: surgery or surveillance.

Hwang EC, Yu HS, Kwon DD.

Korean J Urol. 2013 May;54(5):283-8. doi: 10.4111/kju.2013.54.5.283. Epub 2013 May 14.

19.

Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?

Smaldone MC, Egleston B, Uzzo RG, Kutikov A.

J Urol. 2012 Dec;188(6):2089-94. doi: 10.1016/j.juro.2012.07.099. Epub 2012 Oct 18.

20.

Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma?

Bex A, Kroon BK, de Bruijn R.

Int J Surg Oncol. 2012;2012:250479. doi: 10.1155/2012/250479. Epub 2012 Jun 20.

Supplemental Content

Support Center